Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer

Purpose: High-risk (HR) prostate cancer patients usually receive high-dose radiotherapy (RT) using a two-phase sequential technique, but data on a simultaneous integrated boost (SIB) technique are lacking. We prospectively evaluated the long-term results of urinary (GU) and digestive (GI) toxicity a...

全面介紹

書目詳細資料

Principais autores:	Ingrid Masson, Laurène Larriviere, Marc-André Mahé, David Azria, Pascal Pommier, Nathalie Mesgouez-Nebout, Philippe Giraud, Didier Peiffert, Bruno Chauvet, Philippe Dudouet, Naji Salem, Georges Noël, Jonathan Khalifa, Igor Latorzeff, Catherine Guérin-Charbonnel, Stéphane Supiot
格式:	Artigo
語言:	Inglês
出版:	Elsevier 2024-01-01
叢編:	Clinical and Translational Radiation Oncology
在線閱讀:	http://www.sciencedirect.com/science/article/pii/S2405630823001271
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!